Itau Unibanco Holding S.A.’s Clearside Biomedical CLSD Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-52	Closed	-$1K	–	715
2019 Q1	$1K	Hold	52	–	–	﹤0.01%	586
2018 Q4	$1K	Buy	52 +6	+13%	+$282	﹤0.01%	586
2018 Q3	$4K	Sell	46 -2	-4%	-$238	﹤0.01%	586
2018 Q2	$8K	Buy	48 +20	+71%	+$3.37K	﹤0.01%	713
2018 Q1	$4K	Buy	+28	New	+$3.41K	﹤0.01%	566

Other funds holding CLSD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Itau Unibanco Holding S.A.'s CLSD Position: Q2 2019 in Review

Itau Unibanco Holding S.A. sold out of Clearside Biomedical (CLSD) in Q2 2019, closing a stake of 52 shares — an estimated $1K sold.

Itau Unibanco Holding S.A. first reported a position in CLSD in Q1 2018 and held it in 5 quarters. The position peaked at $8K in Q2 2018. 50 funds tracked by Wall St. Rank hold CLSD as of Q2 2019.

Itau Unibanco Holding S.A. reported no remaining Clearside Biomedical position as of Q2 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 52 Clearside Biomedical shares in Q2 2019, an estimated $1K.
Itau Unibanco Holding S.A. first reported a position in Clearside Biomedical in Q1 2018 and held it in 5 quarters.
Itau Unibanco Holding S.A.'s Clearside Biomedical position peaked at $8K in Q2 2018.
50 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2019, filed 14 Aug 2019.